Literature DB >> 25196854

High prevalence of papillary thyroid cancer in Korean women with insulin resistance.

Min Jung Bae1, Sang Soo Kim2,3, Won Jin Kim2,3, Yang Seon Yi4, Yun Kyung Jeon2,3, Bo Hyun Kim2,3, Byung Joo Lee5, Jin Choon Lee5, In Joo Kim2,3, Soo Geun Wang5, Yong Ki Kim1.   

Abstract

BACKGROUND: The purpose of this study was to determine if hyperinsulinemia and/or insulin resistance are/is associated with the prevalence of papillary thyroid cancer (PTC) in Korean women.
METHODS: This study included 735 female patients with PTC and 537 female non-PTC control subjects. Multiple logistic regression analysis was performed to evaluate the associations between hyperinsulinemia/insulin resistance and the occurrence of PTC.
RESULTS: The prevalence of PTC was significantly correlated with increased insulin, glucose levels, and a high homeostasis model of assessment-insulin resistance (HOMA-IR). The multivariate adjusted odds ratios for the prevalence of PTC in the highest quartile groups for insulin, glucose, and HOMA-IR were 2.88, 9.32, and 4.07 (all p < .001), respectively, compared with the lowest quartile groups. Pathological analyses revealed that increased serum glucose, insulin levels, and a higher HOMA-IR were associated with the multifocality of PTC.
CONCLUSION: Hyperinsulinemia and/or insulin resistance may be associated with the development of PTC, but not disease severity in Korean women.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  hyperglycemia; hyperinsulinemia; insulin resistance; papillary thyroid cancer

Mesh:

Substances:

Year:  2015        PMID: 25196854     DOI: 10.1002/hed.23848

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Raul Zamora-Ros; Virginie Béraud; Silvia Franceschi; Valerie Cayssials; Konstantinos K Tsilidis; Marie-Christine Boutron-Ruault; Elisabete Weiderpass; Kim Overvad; Anne Tjønneland; Anne K Eriksen; Fabrice Bonnet; Aurélie Affret; Verena Katzke; Tilman Kühn; Heiner Boeing; Antonia Trichopoulou; Elisavet Valanou; Anna Karakatsani; Giovanna Masala; Sara Grioni; Maria Santucci de Magistris; Rosario Tumino; Fulvio Ricceri; Guri Skeie; Christine L Parr; Susana Merino; Elena Salamanca-Fernández; Maria-Dolores Chirlaque; Eva Ardanaz; Pilar Amiano; Martin Almquist; Isabel Drake; Joakim Hennings; Maria Sandström; H B As Bueno-de-Mesquita; Petra H Peeters; Kay-Thee Khaw; Nicholas J Wareham; Julie A Schmidt; Aurora Perez-Cornago; Dagfinn Aune; Elio Riboli; Nadia Slimani; Augustin Scalbert; Isabelle Romieu; Antonio Agudo; Sabina Rinaldi
Journal:  Int J Cancer       Date:  2017-07-24       Impact factor: 7.396

Review 2.  Update on Therapeutic Options in Lipodystrophy.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-10-29       Impact factor: 4.810

3.  Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study.

Authors:  Raul Zamora-Ros; Sabina Rinaldi; Konstantinos K Tsilidis; Elisabete Weiderpass; Marie-Christine Boutron-Ruault; Agnetha Linn Rostgaard-Hansen; Anne Tjønneland; Françoise Clavel-Chapelon; Sylvie Mesrine; Verena A Katzke; Tilman Kühn; Jana Förster; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Eleni Klinaki; Giovanna Masala; Sabina Sieri; Fulvio Ricceri; Rosario Tumino; Amalia Mattiello; Petra H M Peeters; H B As Bueno-de-Mesquita; Dagrun Engeset; Guri Skeie; Marcial Argüelles; Antonio Agudo; María-José Sánchez; María-Dolores Chirlaque; Aurelio Barricarte; Saioa Chamosa; Martin Almquist; Ada Tosovic; Joakim Hennings; Maria Sandström; Julie A Schmidt; Kay-Thee Khaw; Nicholas J Wareham; Amanda J Cross; Nadia Slimani; Graham Byrnes; Isabelle Romieu; Elio Riboli; Silvia Franceschi
Journal:  Int J Cancer       Date:  2015-07-30       Impact factor: 7.396

Review 4.  Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Authors:  Roberta Malaguarnera; Veronica Vella; Maria Luisa Nicolosi; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

5.  Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study.

Authors:  Changhua Wu; Liang Wang; Wanjun Chen; Shujuan Zou; Aiju Yang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Circulating adipokines and metabolic setting in differentiated thyroid cancer.

Authors:  Chiara Mele; Maria Teresa Samà; Alessandro Angelo Bisoffi; Marina Caputo; Valentina Bullara; Stefania Mai; Gillian Elisabeth Walker; Flavia Prodam; Paolo Marzullo; Gianluca Aimaretti; Loredana Pagano
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

7.  Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study.

Authors:  Sitong Zhao; Xiaomeng Jia; Xiaojing Fan; Ling Zhao; Ping Pang; Yajing Wang; Yukun Luo; Fulin Wang; Guoqing Yang; Xianling Wang; Weijun Gu; Li Zang; Yu Pei; Jin Du; Jianming Ba; Jingtao Dou; Yiming Mu; Zhaohui Lyu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

8.  High prevalence of thyroid carcinoma in patients with insulin resistance: a meta-analysis of case-control studies.

Authors:  Junyu Zhao; Qianping Zhang; Yupeng Yang; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  Aging (Albany NY)       Date:  2021-09-22       Impact factor: 5.682

9.  Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China.

Authors:  Junyu Zhao; Yutian Tian; Zhen Jia; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

10.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.